Abstract
The following perspective represents our summary of questions, ideas, concerns, and recommendations expressed by speakers and discussants at the second Biennial Translational Preconditioning Workshop held in Miami in December 2011.
MeSH terms
-
Biomarkers, Pharmacological
-
Clinical Trials as Topic
-
Humans
-
Neuroprotective Agents / therapeutic use
-
Stroke / drug therapy
-
Stroke / therapy*
-
Translational Research, Biomedical*
Substances
-
Biomarkers, Pharmacological
-
Neuroprotective Agents